Purchase Order 68HE0B24P0354
Award Date
3/7/24
Potential Completion Date
5/3/24
Potential Value
$25K
Federal Agency
Office of Research and Development
Awardee
Xenotech LLC
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Kansas City, KS 66103, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price federal contract awarded by the National Institute on Drug Abuse (NIDA), a part of the National Institutes of Health (NIH), to Xenotech LLC, doing business as Sekisui-Xenotech. The purpose of the contract is to provide in vitro metabolism and metabolite quantification services over a 5-year period of performance. The total ceiling value of the contract is $1,463,840.30. Xenotech is a small disadvantaged business that specializes in providing biomedical research...
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $45,717 firm fixed price purchase order to Xenotech LLC, doing business as Sekisui-Xenotech, for the provision of cryopreserved human, mouse, and rat hepatocytes. The solicitation sought these hepatocytes for use in drug metabolism experiments to support the National Institute on Drug Abuse's malaria research project and understand drug metabolism in...
This is a purchase order awarded by the U.S. Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse (NIDA) to Xenotech LLC, a small disadvantaged business doing business as Sekisui-Xenotech. The $41,496 firm fixed price contract is for the delivery of 300 vials (1mL each) of "Mixed Gender Human Liver Microsomes" to support the National Center for Advancing Translational Sciences (NCATS) Tox21 program's research on drug metabolism and...
This is a fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The contract is for the delivery of cryopreserved human hepatocytes, which are used to support biomedical research, medical readiness, and other federal initiatives. The contract has a ceiling value of $127,649.76 and a completion date of August 7, 2020. Life Technologies serves as a prime contractor...
This is a firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The $24,262.29 contract is for the delivery of primary human hepatocytes, which are a critical reagent used in biomedical research supported by NCATS. This contract is not associated with any set-aside...
This purchase order contract was awarded by the National Institutes of Health's National Center for Advancing Translational Sciences to Life Technologies Corporation for the delivery of 50 vials of human spheroid-qualified hepatocytes. As described in the original solicitation, these liver cells will support the National Institute on Drug Abuse's Antiviral Program for Pandemics by enabling the continued identification of direct-acting antivirals and development of microphysiological systems...
This is a firm fixed-price delivery order awarded to Evotec US Inc., a foreign-owned, for-profit organization, by the U.S. Environmental Protection Agency's (EPA) Office of Research and Development. The $94,978.26 contract is for services related to the procurement, solubilization, plating, and shipment of chemicals to support the EPA's ToxCast chemical screening program. This order was issued under a larger $16,123,957.10 single-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract...
Xenobiotic Laboratories Inc. was awarded a firm fixed price delivery order against the Analytical Services Center for Medications Development Program for analytical services. The delivery order, valued at $0.00 with a period of performance from September 25, 2019 through May 23, 2022, was issued by the National Institute on Drug Abuse, part of the Department of Health and Human Services National Institutes of Health. Under the delivery order, Xenobiotic Laboratories Inc.'s Biotesting Division...
The Food and Drug Administration (FDA) awarded a $91,630 firm-fixed-price purchase order contract to Discovery Life Sciences, LLC, a small disadvantaged business, for the delivery of 110 vials of primary cryopreserved human hepatocytes. This requirement supports the FDA's National Center of Toxicological Research (NCTR) Division of Biochemical Toxicology's research into drug toxicity and metabolic enzymes. The contract has a period of performance through August 19, 2024 and was awarded under a...
This is a firm fixed price delivery order awarded by the Environmental Protection Agency's Office of Research and Development to Evotec US Inc., a foreign-owned, for-profit organization. The order, valued at $399,804.80, is for toxicology data generation services under the ToxCast chemical prioritization program, including chemical procurement, analysis, sample preparation, and management. Evotec has provided similar services to the EPA under several prior delivery orders against the larger...